Minerva Neurosciences NERV Balance Sheet (2013-2026)

NASDAQ NERV
$4.43 -0.26 (-5.56%)
As of: Sep 4, 2026 · 3:59 PM EDT
Reported Financials

Minerva Neurosciences Quarterly Balance Sheet

Periods 53 quarters
Latest Jun 2026

Minerva Neurosciences reported total assets of $95.09M and total liabilities of $296.65M for the quarter ended Jun 2026, up 212.6% year over year. This balance sheet covers 53 quarters of results from Jun 2013 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
65.59M60.76M54.95M49.75M40.22M36.09M35.98M51.80M46.90M40.91M34.82M30.88M26.53M21.36M17.29M15.25M12.29M82.30M32.66M24.65M
Receivables - OtherOther Receivables
0.78M0.02M
Prepaid Assets
1.75M1.35M0.65M0.18M1.40M0.85M0.60M0.33M1.22M0.99M0.70M0.43M1.31M0.81M0.53M0.20M0.63M0.70M0.94M4.37M
Current Assets
67.44M62.20M55.70M50.04M44.84M40.16M36.67M52.23M48.23M42.00M35.62M31.41M27.94M22.27M17.92M15.55M13.02M83.10M79.11M79.73M
Non-Current Assets
Property, Plant & Equipment (Net)
0.02M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.00M0.00M0.00M
Long-Term Investments
Goodwill
14.87M14.87M14.87M14.87M14.87M14.87M14.87M14.87M14.87M14.87M14.87M14.87M14.87M14.87M14.87M14.87M14.87M14.87M14.87M14.87M
Intangibles
15.20M0.05M0.05M0.05M0.05M0.04M0.04M0.03M0.02M0.02M0.01M0.00M
Goodwill & Intangibles
30.07M14.92M14.92M14.92M14.92M14.91M14.91M14.90M14.89M14.89M14.88M14.87M14.87M14.87M14.87M14.87M14.87M14.87M14.87M14.87M
Other Non-Current Assets
Non-Current Assets
30.12M14.92M14.92M14.92M14.92M14.93M14.92M14.91M14.91M14.90M14.89M14.88M14.88M14.87M14.87M14.87M15.07M14.87M14.92M15.36M
Assets
97.56M77.12M70.62M64.96M59.76M55.09M51.59M67.14M63.13M56.90M50.51M46.29M42.81M37.14M32.80M30.42M28.09M97.97M94.03M95.09M
Liabilities
Current Liabilities
Accounts Payables
1.20M1.85M1.59M1.52M0.53M0.97M0.96M0.30M1.40M1.81M1.44M0.83M0.55M1.61M0.64M0.90M0.94M0.64M2.12M1.45M
Notes Payables
Payables
1.20M1.85M1.59M1.52M0.53M0.97M0.96M0.30M1.40M1.81M1.44M0.83M0.55M1.61M0.64M0.90M0.94M0.64M2.12M1.45M
Accumulated Expenses
1.88M0.97M1.66M1.89M1.66M0.41M1.54M1.61M1.95M1.54M1.40M3.38M3.93M1.23M1.31M1.63M1.73M1.65M2.36M2.51M
Other Accumulated Expenses
Short term Debt
Current Leases
Current Deferred Revenue
Total Current Liabilities
3.08M2.82M3.25M3.41M2.20M1.38M2.50M1.91M3.35M3.34M2.83M4.20M4.48M2.84M1.95M2.53M2.67M2.29M4.48M3.96M
Non-Current Liabilities
Non-Current Debt
Non-Current Deffered Revenue
Preferred Stock Liabilities
4.96M4.96M11.74M
Operating Leases
Non-Current Deferred Tax Liability
1.80M
Other Non-Current Liabilities
64.59M66.33M68.11M69.93M71.81M73.73M75.71M77.74M79.83M82.02M84.27M86.58M60.00M60.00M60.00M60.00M60.00M171.46M278.60M232.69M
Total Non-Current Liabilities
4.89M2.82M3.25M3.41M2.20M1.38M2.50M1.91M3.35M3.34M2.83M4.20M4.48M2.84M1.95M2.53M2.67M62.29M64.48M63.96M
Total Liabilities
69.48M69.15M71.35M73.34M74.00M75.11M78.21M79.65M83.18M85.36M87.10M90.78M64.48M62.84M61.95M62.53M62.67M233.76M343.08M296.65M
Shareholder's Equity
Total Debt
Common Equity
28.08M7.98M-0.74M-8.38M-14.25M-20.02M-26.62M-12.51M-20.05M-28.46M-36.59M-44.49M-21.67M-25.69M-29.15M-32.11M-34.58M-140.75M-254.01M-213.30M
Liabilities and Shareholders Equity
97.56M77.12M70.62M64.96M59.76M55.09M51.59M67.14M63.13M56.90M50.51M46.29M42.81M37.14M32.80M30.42M28.09M97.97M94.03M95.09M
Retained Earnings
-313.40M-334.70M-344.47M-353.20M-360.10M-366.81M-373.80M-380.00M-387.80M-396.82M-405.40M-413.62M-391.10M-395.38M-399.13M-402.40M-405.13M-688.80M-814.20M-796.74M
Treasury Shares
0.00M0.00M0.01M